Hepatitis B remains one of the most persistent viral infections worldwide, affecting hundreds of millions of people chronically according to global health estimates. While modern antiviral therapy such as tenofovir and entecavir has significantly improved outcomes, many patients seek adjunctive support for liver protection, immune balance, and relief from fatigue and digestive weakness that may persist despite viral suppression.

In classical Ayurvedic literature, hepatitis-like presentations are described under yakrit roga (liver disorders) and kamala (jaundice conditions). Kamala is understood as a disorder arising from aggravated pitta, particularly ranjaka pitta located in the liver and blood tissues (rakta dhatu), leading to impaired bile metabolism and systemic discoloration. Clinical features such as yellowing of the eyes and skin, dark urine, pale stools, fatigue, and loss of appetite closely resemble hepatitis presentations.

Within the Ayurvedic framework, the liver (yakrit) is considered a central organ for blood purification and pitta regulation. Management focuses on three coordinated objectives: pacifying aggravated pitta, protecting hepatic tissue, and supporting functional regeneration of liver metabolism. Two herbs most commonly emphasized in this context are katuki (Picrorhiza kurroa) and bhumyamalaki (Phyllanthus niruri).

Katuki (Picrorhiza kurroa): The Bitter Hepatoprotective Herb

Katuki, also known as kutki, is a perennial Himalayan herb traditionally valued for its intensely bitter taste (tikta rasa), which is considered highly effective in pacifying aggravated pitta and supporting liver function. It is primarily used in conditions involving impaired digestion, toxin accumulation, and hepatic sluggishness.

Classical Positioning

Traditional Ayurvedic nighantus describe katuki as beneficial for liver and spleen disorders, fever conditions, and pitta imbalance. It is regarded as a strong bitter herb that supports bile regulation, digestion, and metabolic cleansing processes associated with yakrit function.

Its bitter compounds, mainly iridoid glycosides such as picrosides, are considered responsible for its hepatoprotective and antioxidant activity, supporting its traditional use in liver-related disorders.

Modern Pharmacological Understanding

Experimental and clinical literature has reported hepatoprotective, antioxidant, and anti-inflammatory activity of Picrorhiza kurroa. These effects are attributed to modulation of oxidative stress pathways and support of endogenous antioxidant systems involved in hepatic protection.

Clinical observations in viral hepatitis contexts have noted improvements in liver enzyme patterns and bilirubin metabolism when katuki-based preparations are used as supportive therapy alongside standard medical care.

Dosage and Preparation

Katuki is traditionally administered in several forms depending on patient tolerance and clinical condition:

• Churna (powder): 1–3 grams twice daily with warm water or honey.
• Extract tablets (Ghana Vati): 250–500 mg twice daily for those sensitive to bitter taste.
• Arogyavardhini Vati: 250–500 mg twice daily, used under careful supervision due to its mineral content and multi-herb composition.

Bhumyamalaki (Phyllanthus niruri): The Viral-Targeted Liver Herb

Bhumyamalaki is a small tropical herb widely used in Ayurveda for liver disorders, jaundice conditions, and urinary regulation. It is traditionally classified as pitta-pacifying and supportive in yakrit and spleen-related disorders.

Traditional Context

Bhumyamalaki is described in Ayurvedic texts as beneficial in conditions involving excess pitta, impaired bile flow, and hepatic dysfunction. It is valued for its cooling, detoxifying, and supportive effects on liver metabolism.

Research and Experimental Insights

Experimental studies on Phyllanthus species have reported antiviral activity against hepatitis B virus replication pathways, including inhibition of viral polymerase activity and modulation of viral antigen expression in infected liver cells.

Variability in clinical outcomes has been observed across studies due to differences in plant species, extract preparation, and treatment duration, but hepatoprotective and liver-supportive effects are consistently reported in experimental literature.

Dosage and Preparation

• Fresh juice (swarasa): 10–20 ml twice daily.
• Powder: 3–5 grams twice daily with water.
• Standardized extract: 500 mg twice daily.
• Decoction (kwatha): 50–100 ml twice daily.

The Synergy of Katuki and Bhumyamalaki

In Ayurvedic therapeutics, synergistic combinations (yoga) are designed to address multiple dimensions of disease simultaneously. Katuki and bhumyamalaki complement each other in hepatic disorders by supporting different functional pathways.

Together, these herbs are traditionally used to support liver function, regulate pitta imbalance, and assist in maintaining metabolic stability in chronic hepatic conditions when used alongside appropriate medical supervision.

Clinical Protocol: Supportive Ayurvedic Framework for Chronic Hepatitis B

This protocol represents a traditional Ayurvedic supportive approach used alongside standard antiviral therapy. Individualization based on liver function, viral load, and overall health status is essential.

Phase 1: Assessment and Baseline (Week 1)

Baseline evaluation includes liver function tests (ALT, AST, bilirubin profile, albumin), HBV DNA levels, HBeAg status, complete blood count, and imaging such as ultrasound or FibroScan when available.

Ayurvedic assessment focuses on prakriti (constitution), agni (digestive strength), and signs of pitta-rakta imbalance such as fatigue, digestive irregularity, and skin discoloration.

Phase 2: Active Supportive Care (Months 1–6)

• Katuki churna: 2 grams twice daily before meals with warm water
• Bhumyamalaki churna: 3 grams twice daily after meals
• Aloe vera juice: 15–20 ml once daily on an empty stomach
• Guduchi (Tinospora cordifolia): 500 mg twice daily as an immunomodulatory herb

This herbal protocol is used as an adjunct to antiviral therapy and is not intended to replace prescribed medical treatment. Coordination with the treating physician is essential.

Phase 3: Monitoring

Liver function tests and viral markers are monitored periodically to assess disease progression and hepatic response. Clinical signs such as appetite, energy levels, and digestion are also evaluated as part of overall assessment.

Phase 4: Maintenance

After initial improvement, lower maintenance doses may be used under supervision to support ongoing liver health and metabolic balance.

Dietary Framework for Liver Support

Diet plays a central role in Ayurvedic management of hepatic disorders. A pitta-pacifying dietary approach is recommended.

• Recommended: Bitter vegetables, leafy greens, mung dal, barley, pomegranate, grapes, and lightly prepared warm foods.
• Avoid: Alcohol, excessively spicy foods, deep-fried foods, processed foods, and excessive sour or fermented items.
• Carrier substances: Warm water or buttermilk may be used to support herbal absorption and digestion.

Safety Considerations

Herbal interventions must be used cautiously in chronic liver disease. Dose adjustments are required in advanced liver impairment. Immunomodulatory herbs should be used carefully in patients on immunosuppressive therapy. Katuki and bhumyamalaki are not recommended during pregnancy. Professional supervision is essential in all cases involving chronic hepatitis B.

Clinical Perspective

Chronic hepatitis B requires lifelong monitoring and coordinated care. Ayurvedic herbal support may assist in maintaining liver function, digestive strength, and overall well-being when used alongside antiviral therapy and regular medical supervision. Consistency, individualized dosing, and integration with modern hepatology provide the most balanced approach.

Medical Disclaimer: This content is for educational purposes only. Hepatitis B is a serious medical condition requiring supervision by qualified healthcare professionals. Ayurvedic interventions should be used only as supportive care alongside standard treatment and under expert guidance.

This article does not diagnose or treat disease. Always consult a qualified physician before starting or modifying any treatment.

References

1. World Health Organization
2. En (en.wikipedia.org)
3. En (en.wikipedia.org)
4. En (en.wikipedia.org)